Department of Radiation Oncology, American Oncology Institute- DMC Care Centre, Ludhiana, Punjab, India.
Department of Medical Physis, American Oncology Institute, Hyderabad, Telangana, India.
J Cancer Res Ther. 2024 Jul 1;20(5):1591-1594. doi: 10.4103/jcrt.jcrt_1697_23. Epub 2024 Sep 19.
Peer review is an essential step in clinical quality assurance for radiation therapy. There are very little data on peer reviews from low-middle-income countries (LMIC). With increasing access to advanced technologies in LMIC also, peer review is becoming more important to ensure quality and standard of care. We evaluated cloud-based e-Peer review in our network of cancer centers in India with an aim to study its feasibility and impact on care.
Four out of 13 cancer centers across India were selected for this pilot study. All team members were trained on the e-Peer review platform before the initiation of the study. A lead dosimetrist from a centralized planning site was selected to share new cases every week. Cases treated with only definitive intent were selected. The link to the cases was sent through an email to reviewing physicians. The following aspects were reviewed for each case. 1) Work up and staging. 2) Treatment intent and prescription. 3) Target contours. 4) Normal organ at risk contours. 5) Dose-volume-histogram (DVH) with clinical goals attached. Cases were marked as "Not Appropriate," "Appropriate," "Appropriate with minor finding," and "Represent with major revisions" as per volume and plan review.
Over a period of 3 months, 100 cases underwent peer review before the start of treatment. Median turnover time was 48 (interquartile range: 24-96) hours. The median time for review was 8 min with time to review cases requiring major and minor changes being 12 and 6 min, respectively (P < 0.001). Of all the cases reviewed, no changes, minor changes, and major changes were suggested for 36%, 48%, and 16% of cases, respectively. The most frequent reason for major changes was contouring corrections (15%). Also, 31.3% of major changes underwent recontouring and replanning before initiation of treatment.
Peer review was feasible in our setting through this cloud-based peer review system, with median turnover time and time taken for review being 48 h and 8 min, respectively. Like published data from the Western world, peer review led to changes that could impact patient care delivery and outcome. We plan to implement this across the remaining centers in our network.
同行评议是放射治疗临床质量保证的重要步骤。来自中低收入国家(LMIC)的同行评议数据非常少。随着 LMIC 获得更多先进技术,同行评议对于确保质量和护理标准变得更加重要。我们在印度的癌症中心网络中评估了基于云的电子同行评议,旨在研究其可行性及其对护理的影响。
在这项试点研究中,从印度的 13 个癌症中心中选择了 4 个。在研究开始之前,所有团队成员都接受了电子同行评议平台的培训。从集中规划站点选择一名首席剂量师每周分享新病例。仅选择采用确定性治疗意图的病例。通过电子邮件将病例链接发送给审查医师。每个病例都要审查以下方面。1)检查和分期。2)治疗意图和处方。3)靶区轮廓。4)正常器官危及器官轮廓。5)附有临床目标的剂量-体积-直方图(DVH)。根据体积和计划审查,病例被标记为“不适当”、“适当”、“适当但有小发现”和“需要重大修订”。
在治疗开始前的 3 个月内,有 100 例病例接受了同行评议。中位周转时间为 48 小时(四分位距:24-96 小时)。审查时间中位数为 8 分钟,需要进行重大和较小更改的病例的审查时间分别为 12 分钟和 6 分钟(P <0.001)。在所有审查的病例中,分别有 36%、48%和 16%的病例没有变化、有较小变化和有较大变化。建议进行重大更改的最常见原因是轮廓校正(15%)。此外,在开始治疗之前,有 31.3%的重大更改病例需要重新轮廓和重新计划。
通过这个基于云的同行评议系统,在我们的环境中同行评议是可行的,中位周转时间和审查时间分别为 48 小时和 8 分钟。与来自西方世界的已发表数据一样,同行评议导致了可能影响患者护理交付和结果的更改。我们计划在网络中的其余中心实施这一措施。